Regulatory report: South Korea

$300.00

Contents:

1 Executive summary
2 Hemp plant
3 Extracts as finished product
4 Finished products containing CBD and extracts
5 Import and export requirements
6 Medical and recreational cannabis
7 Relevant laws
8 Relevant bodies

Category: Tags: , , ,

Description

The South Korean market is predominantly reserved for medical cannabis, and while CBD consumer products remain illegal, an association recently started a petition to decriminalise cannabis usage. This report provides a detailed analysis of the regulatory regime for hemp and cannabis in South Korea, providing information relating to extracts and finished products, import and export laws, and current regulation around medical and recreational cannabis.

No. of pages: 10

Photo: Mathew Schwartz

CBD-Intel does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of CBD-Intel, does not accept any liability or responsibility for information or views published.